Patents/Inventors

Johannes Sam

SchlierenCH13 patents

6 Patents

US126007812026
Tumor-targeted Agonistic CD28 Antigen Binding Molecules
Hoffmann-la Roche Inc.
0 cites
US122811532025
Combination Therapy with Targeted 4-1BB (CD137) Agonists
Hoffmann-la Roche Inc.
0 cites
US120982132024
Antibodies Binding to HLA-A2/WT1
Hoffmann-la Roche Inc.
0 cites
US117809192023
Bispecific Antigen Binding Molecules Targeting OX40 and FAP
Hoffmann-la Roche Inc.
0 cites
US117186802023
Combination Therapy of Anti-cd20/anti-cd3 Bispecific Antibodies and 4-1BB (CD137) Agonists
Hoffmann-la Roche Inc.
0 cites
US116083762023
Tumor-targeted Agonistic CD28 Antigen Binding Molecules
Hoffmann-la Roche Inc.
0 cites